| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2001002556A3 Agents for the diagnosis, prognosis and treatment of malignant diseases |
| 08/16/2001 | WO2000078983A3 Sunflower anti-pathogenic proteins and genes and their uses |
| 08/16/2001 | WO2000065055A8 Human transporter proteins |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 08/16/2001 | WO2000055307A3 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor |
| 08/16/2001 | WO2000050077A9 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| 08/16/2001 | WO2000049132A3 Uses of transgenic animals containing a type x collagen mutant |
| 08/16/2001 | WO2000046367A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | WO2000044782B1 Ewing's tumour antigen, nucleic acid and antibodies |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | WO2000004156A3 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 08/16/2001 | WO2000003025A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | WO1999050658A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | US20010014977 DNA sequence encoding protein for pigment synthesis; modifying color phenotype of plant tissue |
| 08/16/2001 | US20010014734 Controllers |
| 08/16/2001 | US20010014732 Biocidal proteins |
| 08/16/2001 | US20010014673 Genetic engineering |
| 08/16/2001 | US20010014672 High molecular weight major outer membrane protein of moraxella |
| 08/16/2001 | US20010014668 Colonization factor antigens; epitopes; immunization against diarrheagenic Escherichia |
| 08/16/2001 | US20010014666 Solution comprises purified glucagon-like peptide-1, buffering agent containing alcohol or mono/di- saccharide, and optionally ammonium sulfate; tetragonal flat rod shaped crystals formed; useful in treating diabetes and obesity |
| 08/16/2001 | US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014471 Antitumor agents |
| 08/16/2001 | US20010014470 Polypeptide having antigenic determinant identical to antigenic determinant of a protein produced by cells infected with simian T-lymphotrophic virus or HTLV-IV, the protein selected from cell-surface glycoproteins, gag proteins |
| 08/16/2001 | US20010014469 Comprising a cytotoxic agent and a pest gut epithelial cell recognition portion of a protein, said cytotoxic agent and recognition portion not being naturally contiguous |
| 08/16/2001 | US20010014465 Human 4-1BB receptor splicing variant |
| 08/16/2001 | US20010014464 Nucleic acid encoding follistatin-3 |
| 08/16/2001 | US20010014458 Human G-protein coupled receptor GPR6sb |
| 08/16/2001 | US20010014457 The receptors, and antibodies; screening for a compound capable of interacting with any of these receptors |
| 08/16/2001 | US20010014456 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/16/2001 | US20010014455 Assay for disease related conformation of a protein and isolating same |
| 08/16/2001 | US20010014447 Methods for the detection of encysted parasites |
| 08/16/2001 | US20010014337 A peptide having substantial homology with the CBF1/RBPJk (cell binding factor-1/recombination bining protein J kappa) interaction domain of EBNA2 comprising specific peptide containing 15-20 amino acids |
| 08/16/2001 | US20010014335 A fusion protein comprising a polypeptide having antigenicity of Mycoplasma gallisepticum and a polypeptide derived from herpesvirus outer membrane protein being ligated with polypeptide having antigenicity of mycoplasma at N-terminum |
| 08/16/2001 | US20010014333 Hybrid heterodimeric protein hormone and method of using same |
| 08/16/2001 | US20010014332 Modified immunogenic pneumolysin compositions as vaccines |
| 08/16/2001 | US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen |
| 08/16/2001 | US20010014327 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | EP1144997A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
| 08/16/2001 | EP1144661A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | EP1144627A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | EP1123978A1 A cytochrome P450 gene highly expressed in the incompatible interaction |
| 08/16/2001 | EP1123977A1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
| 08/16/2001 | EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 08/16/2001 | EP1123692A2 Use of polyaminoacid derivatives for the treatment of Seborrhea and related cutaneous disorders |
| 08/16/2001 | EP1123418A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 08/16/2001 | EP1123407A2 Apomixis conferred by expression of serk interacting proteins |
| 08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
| 08/16/2001 | EP1123404A2 Materials and methods for the modification of plant cell wall polysaccharides |
| 08/16/2001 | EP1123403A1 OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF |
| 08/16/2001 | EP1123402A2 Nucleic acids that control reproductive development in plants |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123400A1 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect |
| 08/16/2001 | EP1123399A2 Production and use of modified cystatins |
| 08/16/2001 | EP1123398A2 Molecular pathogenicide mediated plant disease resistance |
| 08/16/2001 | EP1123397A2 G-protein coupled receptors |
| 08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 08/16/2001 | EP1123394A2 Proliferation and apoptosis related proteins |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123391A2 Methods for improving the function of heterologous g protein-coupled receptors |
| 08/16/2001 | EP1123389A1 A method of affinity separation and ligands for use therein |
| 08/16/2001 | EP1123388A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 08/16/2001 | EP1123387A2 Mn gene and protein |
| 08/16/2001 | EP1123385A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 08/16/2001 | EP1123383A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/16/2001 | EP1123316A1 Protein engineering |
| 08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
| 08/16/2001 | EP1123314A2 USE OF A CYTOKINE-PRODUCING $i(LACTOCOCCUS) STRAIN TO TREAT COLITIS |
| 08/16/2001 | EP1123313A2 Methods and compositions for the prevention and treatment of anemia |
| 08/16/2001 | EP1123312A2 Human rna binding proteins |
| 08/16/2001 | EP1123311A1 Isolated proteins and nucleic acid molecules having homology to the nip2 protein and uses thereof |
| 08/16/2001 | EP1123306A1 Inhibitors of platelet activation and recruitment |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
| 08/16/2001 | EP1123108A1 Isolated peptides which bind to hla-b35 molecules |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123004A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 08/16/2001 | EP1007630A4 Natural killer cell lines and methods of use |
| 08/16/2001 | EP0846263A4 A method and kit for evaluating the metastatic tendency of tumors |
| 08/16/2001 | EP0827547B1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof |
| 08/16/2001 | EP0820523A4 Conserved yeast nucleic acid sequences |
| 08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
| 08/16/2001 | EP0749444B1 Hybrid human/animal factor viii |
| 08/16/2001 | EP0731843B1 Tyrosinase-activator protein fusion enzyme |
| 08/16/2001 | EP0698097B1 Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae |
| 08/16/2001 | EP0670729B1 Use of insulin-like growth factors and analogs for TREATING RETINAL NEURONAL DISORDERS |
| 08/16/2001 | EP0576483B1 Biocidal proteins |
| 08/16/2001 | DE10064343A1 Nukleinsäure für die Untersuchung des proteasomalen Proteinabbaus Nucleic acid for the investigation of the proteasomal protein degradation |
| 08/16/2001 | DE10045182A1 Verwendung von Palatinase- und Trehalulase-Sequenzen als nutritive Marker in transformierten Zellen Use of palatinase and trehalulase sequences as nutritional markers in transformed cells |
| 08/16/2001 | DE10006201A1 New genes involved in oxidation of reduced sulfur compounds, particularly conversion of thiosulfate to sulfate, and related proteins, from Paracoccus pantotrophus |
| 08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
| 08/16/2001 | DE10004447A1 Verfahren zur Verhinderung von Tumorwachstum A method for preventing tumor growth |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2400802A1 Compositions and methods for screening therapeutic agents |